The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
The Elusive Link Between LQT3 and Brugada Syndrome: The Role of Flecainide Challenge
Open accessAbstract
Background —Defects of the SCN5A gene encoding the cardiac sodium channel are associated with both the LQT3 subtype of long-QT syndrome and Brugada syndrome (BS). The typical manifestations of long-QT syndrome (QT interval prolongation) and BS (ST segment elevation in leads V1 through V3) may coexist in the same patients, which raises questions about the actual differences between LQT3 and BS. Intravenous flecainide is the standard provocative test used to unmask BS in individuals with concealed forms of the disease, and oral flecainide has been proposed as a treatment option for LQT3 patients because it may shorten their QT interval. Methods and Results —We tested the possibility that in some LQT3 patients, flecainide might not only shorten the QT interval, but also produce an elevation of the ST segment. A total of 13 patients from 7 LQT3 families received intravenous flecainide using the protocol used for BS. As expected, QT, QTc, JT, and JTc interval shortening was observed in 12 of the 13 patients, and concomitant ST segment elevation in leads V1 through V3 (≥2 mm) was observed in 6 of the 13. Conclusions —The data demonstrate that flecainide may induce ST segment elevation in LQT3 patients, raising concerns about the safety of flecainide therapy and demonstrating the existence of an intriguing overlap between LQT3 and BS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cardiac Electrophysiology: From Cell to Bedside
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-12-1069_5 · Cited by 2,385
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
Chen, Q., Kirsch, G. E., Zhang, D., Brugada, R., Brugada, J., Brugada, P., Potenza, D., Moya, A., Borggrefe, M., Breithardt, G., et al. (1998) · Nature · doi:10.1038/32675 · Cited by 1,831
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
Wang, Q., Shen, J., Splawski, I., Atkinson, D., Li, Z., Robinson, J. L., Moss, A. J., Towbin, J. A., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90359-3 · Cited by 1,686
Diagnostic criteria for the long QT syndrome. An update.
Schwartz, P. J., Moss, A. J., Vincent, G. M., & Crampton, R. S. (1993) · Circulation · doi:10.1161/01.cir.88.2.782 · Cited by 1,181
Self-citationSchwartz, P. J., Priori, S. G., Locati, E. H., Napolitano, C., Cantù, F., Towbin, J. A., Keating, M. T., Hammoude, H., Brown, A. M., Chen, L.-S. K., et al. (1995) · Circulation · doi:10.1161/01.cir.92.12.3381 · Cited by 816
Self-citationLow Penetrance in the Long-QT Syndrome: Clinical Impact
Priori, S. G., Napolitano, C., & Schwartz, P. J. (1999) · Circulation · doi:10.1161/01.cir.99.4.529 · Cited by 804
Self-citationBrugada, R., Brugada, J., Antzelevitch, C., Kirsch, G. E., Potenza, D., Towbin, J. A., & Brugada, P. (2000) · Circulation · doi:10.1161/01.cir.101.5.510 · Cited by 772
Influence of the Genotype on the Clinical Course of the Long-QT Syndrome
Zareba, W., Moss, A. J., Schwartz, P. J., Vincent, G. M., Robinson, J. L., Priori, S. G., Benhorin, J., Locati, E. H., Towbin, J. A., Keating, M. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391404 · Cited by 754
Self-citationA Single Na + Channel Mutation Causing Both Long-QT and Brugada Syndromes
Bezzina, C., Veldkamp, M. W., van den Berg, M. P., Postma, A. V., Rook, M. B., Viersma, J.-W., van Langen, I. M., Tan-Sindhunata, G., Bink-Boelkens, M. T. E., van der Hout, A. H., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.12.1206 · Cited by 656
The Spectrum of Symptoms and QT Intervals in Carriers of the Gene for the Long-QT Syndrome
Vincent, G. M., Timothy, K. W., Leppert, M., & Keating, M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209173271204 · Cited by 622
Cited by
Zeppenfeld, K., Tfelt-Hansen, J., de Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,140
Self-citationProposed Diagnostic Criteria for the Brugada Syndrome: Consensus Report
Wilde, A. A. M., Antzelevitch, C., Borggrefe, M., Brugada, J., Brugada, R., Brugada, P., Corrado, D., Hauer, R. N. W., Kass, R. S., Nademanee, K., et al. (2002) · Circulation · doi:10.1161/01.cir.0000034169.45752.4a · Cited by 827
Self-citationLong-QT Syndrome: From Genetics to Management
Schwartz, P. J., Crotti, L., & Insolia, R. (2012) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.111.962019 · Cited by 659
Self-citationPrevalence of Long-QT Syndrome Gene Variants in Sudden Infant Death Syndrome
Arnestad, M., Crotti, L., Rognum, T. O., Insolia, R., Pedrazzini, M., Ferrandi, C., Vege, A., Wang, D. W., Rhodes, T. E., George, A. L., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.658021 · Cited by 549
Self-citationRoden, D. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmcp0706513 · Cited by 380
Metadata
- Authors
- Priori, S. G., Napolitano, C., Schwartz, P. J., Bloise, R., Crotti, L., & Ronchetti, E.
- Venue
- Circulation
- Published
- 2000-08-29
- Volume
- 102
- Issue
- 9
- Pages
- 945-947
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2107224600
- Cited by
- 267
- References
- 15
- FWCI
- 13.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Elusive Link Between LQT3 and Brugada Syndrome: The Role of Flecainide Challenge. https://app.cochat.ai/papers/10.1161/01.cir.102.9.945
- The paper
- Priori, S. G., Napolitano, C., Schwartz, P. J., Bloise, R., Crotti, L., & Ronchetti, E. (2000). The Elusive Link Between LQT3 and Brugada Syndrome: The Role of Flecainide Challenge. Circulation. https://doi.org/10.1161/01.cir.102.9.945
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.